Inflation of Sibling Recurrence-Risk Ratio, Due to Ascertainment Bias and/or Overreporting  by Guo, Sun-Wei
Am. J. Hum. Genet. 63:252–258, 1998
252
Inflation of Sibling Recurrence-Risk Ratio, Due to Ascertainment Bias and/
or Overreporting
Sun-Wei Guo
Institute of Human Genetics and Division of Epidemiology, University of Minnesota, Minneapolis
Summary
One widely used measure of familial aggregation is the
sibling recurrence-risk ratio, which is defined as the ratio
of risk of disease manifestation, given that one’s sibling
is affected, as compared with the disease prevalence in
the general population. Known as lS, it has been used
extensively in the mapping of complex diseases. In this
paper, I show that, for a fictitious disease that is strictly
nongenetic and nonenvironmental, lS can be dramati-
cally inflated because of misunderstanding of the original
definition of lS, ascertainment bias, and overreporting.
Therefore, for a disease of entirely environmental origin,
the lS inflation due to ascertainment bias and/or over-
reporting is expected to be more prominent if the risk
factor also is familially aggregated. This suggests that,
like segregation analysis, the estimation of lS also is
prone to ascertainment bias and should be performed
with great care. This is particularly important if one uses
lS for exclusion mapping, for discrimination between
different genetic models, and for association studies,
since these practices hinge tightly on an accurate esti-
mation of lS.
Introduction
Familial aggregation of diseases is generally taken as
evidence for the existence of a genetic etiologic mech-
anism, environmental factors common to family mem-
bers, or a combination of both (e.g., see MacMahon
1978). An important goal for many genetic epidemio-
logical studies is to demonstrate familial aggregation of
a disease (Khoury et al. 1993). Once the evidence for
familiality is well established, family history can be used
to identify high-risk individuals. In addition, further
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analysis, such as segregation analyses, can be performed
to delineate the genetic component and the mode of
inheritance, which often are followed by linkage analysis
to map the gene(s) responsible for the disease.
Since gene mapping, especially that based on ge-
nomewide screening, often is costly and time-consuming,
it is vital, as a first step toward the understanding of the
genetic mechanism underlying the disease of interest, to
measure the familial aggregation as accurately as pos-
sible. One widely used measure for familial aggregation
is the sibling recurrence-risk ratio, which is defined as
the ratio of risk of disease manifestation, given that one’s
sibling is affected, compared with the disease prevalence
in the general population. A significant deviation from
unity in this measure suggests familial aggregation.
The idea of using the sibling recurrence-risk ratio to
gauge familial aggregation or hereditary background of
a disease can be traced back to Penrose (1953), and its
use in the mapping of complex traits has been greatly
extended by Risch’s three seminal papers (Risch 1990a,
1990b, 1990c). Known as “lS,” it now has been used
extensively in discriminating between different ge-
netic models underlying complex diseases such as
non–insulin-dependent diabetes mellitus (Rich 1990),
multiple sclerosis (Sadovnick 1994), and cleft lip with
or without cleft palate (Farrall and Holder 1992) and
in the mapping, inclusion, and exclusion of complex
traits (e.g., see Kruglyak and Lander 1995; Risch and
Merikangas 1996).
It is self-evident that “familial” is not necessarily “ge-
netic” or “hereditary”; for example, scurvy, kuru, hep-
atitis B, and sudden infant death syndrome were once
mistakenly thought to be hereditary because of their ten-
dency to “run in families,” but later this was found to
be untrue. However, Khoury et al. (1988) demonstrate,
on theoretical grounds, that, for a disease with a strong
familial aggregation, environmental risk factors alone
are unlikely to account for such strong aggregation, un-
less the presumed environmental risk factors are asso-
ciated with enormous risk (which should be easy to de-
tect in the first place).
The conclusion reached by Khoury et al. (1988), how-
ever, is based on three critical assumptions. First, human
populations consist of exclusively nuclear families, each
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with two offspring only; or, alternatively, for a nuclear
family with more than two offspring, once the family
has been ascertained, the affection status of a randomly
selected sibling is determined and taken into the esti-
mation of the recurrence-risk ratio. Second, sampling
from the population is strictly random and is free of
biases of any kind. Third, the affection status in relatives
of an index subject can be determined without error.
In many genetic epidemiological studies, these three
assumptions often are not satisfied, either individually
or jointly. Sampling is, by choice and necessity, often
anything but random. A sibship with multiple affected
individuals may be more likely to enter into the sample.
The affection statuses in relatives of the index subject
typically are determined on the basis of his or her report,
because of constraints in time and resources. Index sub-
jects, if affected, may be more likely to be aware of the
diagnosis in their relatives and may be more diligent in
their search for additional cases. They also may be more
likely to misinterpret, say, benign tumor as cancer, or
angina as myocardial infarction, in their relatives. Fur-
ther compounding the potential problems in the three
assumptions discussed above is the misunderstanding
and misuse of lS, as we shall see below.
In this paper, I will show that, for a fictitious disease
that is strictly nongenetic and nonenvironmental, lS can
be dramatically inflated because of misunderstanding of
the original definition of lS, ascertainment bias, and ov-
erreporting. Therefore, for a disease of entirely environ-
mental origin, the lS inflation due to ascertainment bias
and/or overreporting is expected to be more prominent
if the risk factor also is familially aggregated. This sug-
gests that, like segregation analysis, the estimation of lS
also is prone to ascertainment bias and should be per-
formed with great care. This is particularly important if
we use lS for exclusion mapping, for discriminating be-
tween different genetic models, and for association
studies.
Methods
Consider a disease with population frequency p. Sup-
pose that each individual in the population is equally
liable to succumb to the disease and that the disease can
be detected at any time after birth (i.e., no variable age
at onset). Suppose also that there is no birth-order effect,
no cohort effect, and no sex difference. In addition, sup-
pose that the disease or trait has nothing to do with
genes or environmental risk factors. Thus, the affection
status of any individual is entirely independent of those
of others, including his siblings. Conceptually, one can
view the affection status of any individual as being de-
termined, effectively, by flipping a biased coin with a
head probability of p.
If D denotes that an individual is affected with the
disease, the sibling recurrence-risk ratio is defined as:
P(sib2 DFsib1 D)
l S p
(Khoury et al. 1988; Risch 1990a). If Xi denotes the
affection status of sib i ( ), with if sib i isi  1,2 X  1i
affected or if sib i not, then the definitions givenX  0i
above can written more compactly, as
P(X  1FX  1)2 1
l  . (1)S p
For the fictitious disease that we are considering, lS
should be unity if the three critical assumptions of
Khoury et al. (1988) are invoked.
In practice, however, any population, at the nuclear-
family level, is composed of families having zero, one,
two, or more offspring, and the distribution of sibship
size can be empirically estimated from, say, census data.
Clearly, for any genetic epidemiological study, any as-
certained family with zero or one child would have to
be discarded for the purpose of estimating lS. For fam-
ilies with exactly two offspring, the estimation of lS can
be made accurately as long as these families are both
randomly ascertained and free of overreporting and the
designation of “sib1” or “sib2” is independent of their
affection statuses.
For families with k ( ) offspring, however, the def-k 1 2
inition given above is somewhat ambiguous. Which sib
should be designated as “sib1” or as “sib2”? Which sib
should be included if there are multiple affected sibs?
Without careful consideration of these issues, the resul-
tant estimates would be meaningless.
A more serious problem is that sibships of different
sizes are usually ascertained with different probabilities.
In particular, sibships with a greater number of affected
individuals usually have a higher probability of being
ascertained, simply because they are more conspicuous
or easier to ascertain or, in the case of a cross-sectional
survey, because of their eagerness to participate or to
seek medical attention. Worse yet, the event “sib1 D”
is sometimes taken as the index case and the event “sib2
D” is taken as “at least one affected among the rest of
the sibship,” or the other way around.
In many genetic epidemiological studies, one typical
procedure is to take a group of individuals known to
have the disease or trait in question and to determine
the frequency of its occurrence among relatives within
a specified degree of kinship—in particular, siblings—as
Haenszel observed as early as 1959 (Haenszel 1959).
This is the case, for example, in two genetic epidemio-
logical studies of homosexuality (Pillard and Weinrich
1986; Bailey and Benishay 1993), in which homosexual
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subjects were recruited through advertisements andwere
used as index subjects and in which the sexual orien-
tations of their same-sex siblings subsequently were de-
termined. Thus, in effect, definition (1) becomes
k
P  X x 1FX  1,A( )i 1
i2∗
l  , (2)S p
where sib1 is designated as an index individual, de-A
notes the event that this sibship has been ascertained,
and the event denotes that there is at leastk X x 1i2 i
one affected sibling of sib1.
On the other hand, some studies, especially cross-sec-
tional surveys, determine the affection status of the index
subject through medical examinations and estimate the
disease prevalence in the index subjects, given that one
or more siblings are affected (e.g., see Monroe et al.
1995; Narod et al. 1995). Consequently, definition (1)
effectively becomes
k
P X  1F  X x 1,A( )1 i
i2∗∗l  . (3)S p
It should be noted that definitions (2) and (3) do not
agree with definition (1), even if (for two-offspringk  2
families), because of potential ascertainment bias. For
, definitions (2) and (3) for sibling recurrence-riskk 1 2
ratio are not, even without ascertainment bias, intended
in the original definition of lS (Risch 1990a), but they
nonetheless have been used in some genetic epidemio-
logical studies.
Impact of Ascertainment Bias on lS
Although there are countless ways to ascertain a sib-
ship, I consider the scenario in which case there is a
constant probability p that any affected individual be-
comes an index case and that ascertainments of different
affected individuals are assumed to be independent (Bai-
ley 1951). Under this scheme, which is termed “multiple
ascertainment” (Ewens 1991), the probability that a sib-
ship with r affected individuals contains at least one
index case and thus enters the sample is . Inr1 (1 p)
other words, .k rP(AF X  r)  1 (1 p)i1 i
Now, if and ,d  1 p q  1 p
k1∗l  P X x 1FX  1,A( )S i 1p i2
k
P X  1,  X x 1,A( )1 i
i21

p P(X  1,A)1
k1 k P X  1,  X  j,A( )1 i
j1 i21
 k1 kp  P X  1,  X  j,A( )1 i
j0 i2
k1 k k P AFX  1,  X  j P X  1,  X  j( ) ( )1 i 1 i
j1 i2 i21
 k1 k kp  P AFX  1,  X  j P X  1,  X  j( ) ( )1 i 1 i
j0 i2 i2
k1k1
j1 j k1j( )j (1 d )p p q1 j1 k1p j1 j k1j (1 d )p p qk1
j0 ( )j
k1 k11pq  (1p)(1 pp)
 .k1p[1 (1p)(1 pp) ]
Similarly, if definition (3) is used, it can be shown that
k1∗∗l  P X  1F X x 1,A( )S 1 ip i2
k1 k11 pq  (1 p)(1 pp)
 .k k11 (1 pp)  ppq
Since the sample size of many genetic epidemiological
studies is small relative to the size of the population from
which the sample is drawn, and since the frequency of
most diseases is not high (say, !10%), p is usually small,
unless all cases are completely ascertained. Conse-
quently, the ascertainment probabilities for a sibship
with 0,1, . . . ,k affected individuals are proportional to
, which approach 0:2 k)0:p:[1 (1 p) ]: :[1 (1 p) ]
1:2:):k as . In human genetics, this special casep r 0
is referred to as “single ascertainment” (Ewens 1991),
because there is only one index case in each ascertained
sibship.
Under single ascertainment, since
k
P X x 1FX  1,A( )i 1
i2
k
P X  1,  X x 1,A( )1 i
i2

P(X  1,A)1
2 2 k2)p (k q q   q )
 ;2 2 k2 k1)p (k q q   q ) pq
then,
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k2)k q  q∗l  .S k (k 1)q
If definition (4) is used, it can be shown that
k2)k q  q∗∗l  .S k1k q
It is easy to see that both and are 11, regardless∗ ∗∗l lS S
of the value of p.
Impact of Ascertainment Bias and/or Overreporting
Error on lS
In many epidemiological studies, the affection statuses
in relatives of an index subject are usually determined
by his or her report. It is likely that the subject would
overreport the affection status in his or her siblings. For
example, angina could be mistakenly construed as myo-
cardial infarction. This overreporting is more likely to
happen if adult siblings live in different geographic areas
and/or if the disease is not severe (J. T. Bensen, A. D.
Liese, J. T. Rushing, M. Province, A. R. Folsom, and D.
Arnett, personal communication).
Now, suppose that, for the siblings of the index sub-
ject, their affection status is denoted as Yi, ( )i  2,...,k
and that the overreporting, or false-positive, rate is a;
that is, . Suppose also that the af-P(Y  1FX  0)  ai i
fection status of the index subject is always determined
without error. This happens when the index subjects can
be examined thoroughly or are known to be affected.
Moreover, the ascertainment scheme is such that the
probability that a sibship is ascertained depends only on
the number of apparently affected individuals. In par-
ticular, I continue to consider the scheme in which
k
P A FY  1, Y  j ∝ (j 1) .( )1 i
i2
Hence,
k
P Y  j( )i
i2
j k k k
 P X  l P Y  jF X  l   ( ) ( )i i i
l0 i2 i2 i2
j
k1 l k1l jl k1jk1l p q a (1 a) ( ) ( )l jll0
j lpk1j j k1j jlk1 j q a (1 a) q ( )( ) ( )j l al0
j k1jk1 (p qa) [q(1 a)] .( )j
Therefore,
k
P Y ≥ 1FY  1,A( )i 1
i2
k1 k P Y  1,  Y  j,A( )1 i
j1 i2
 k1 k P Y  1,  Y  j,A( )1 i
j0 i2
k1k1
j k1j( )j (j 1) (p qa) [q(1 a)]
j1 .k1
j k1j (j 1) (p qa) [q(1 a)]k1
j0 ( )j
Hence, we have
k1∗l  P Y x 1FY  1,A( )S i 1p i2
k1 k1(k 1)(p qa) 1 q (1 a)
 .
p[(k 1)(p qa) 1]
When , this equation reduces toa  0
k1(k 1)p 1 q∗l  ,S p[(k 1)p 1]
which agrees with definition (4). By means of definition
(3), it can be shown that
k1∗∗l  P Y  1F Y ≥ 1,A( )S 1 ip i2
k1 k1(k 1)(p qa) 1 q (1 a)
 .k1 k1(k 1)(p qa) p[1 q (1 a) ]
Since , is always 11.∗∗q(1 a) ! 1 lS
Results
Table 1 shows and under the multiple-ascer-∗ ∗∗l lS S
tainment scheme when the ascertainment probability is
. As expected, under this ascertainment scheme,p  .05
if the sibship size is 2 but is if the sibship∗ ∗∗ ∗ ∗∗l  l l 1 lS S S S
size is 12. In view of the independence in the affection
status, the probability that at least one sibling of the
index subject is affected increases with the sibship size,
given that the index subject is affected and that the sib-
ship is ascertained. Thus increases as the sibship size∗lS
increases. On the other hand, the probability that the
index subject is affected decreases with the sibship size,
given that at least one sibling of the rest of the sibship
is affected and that the sibship is ascertained.
In general, the inflation of either or becomes∗ ∗∗l lS S
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Table 1
Sibling Recurrence-Risk Ratios When Ascertainment Bias Is
Introduced
p AND RECURRENCE RISK
VALUE FOR SIBSHIP SIZE OF
2 3 4 5 6
.30:
∗lS 1.52 2.29 2.71 2.95 3.10
∗∗lS 1.52 1.45 1.40 1.35 1.32
.20:
∗lS 1.64 2.68 3.36 3.83 4.15
∗∗lS 1.64 1.58 1.53 1.49 1.45
.10:
∗lS 1.78 3.19 4.32 5.24 5.98
∗∗lS 1.78 1.74 1.71 1.68 1.65
.05:
∗lS 1.86 3.51 4.99 6.30 7.48
∗∗lS 1.86 1.84 1.82 1.80 1.78
.03:
∗lS 1.90 3.66 5.30 6.84 8.27
∗∗lS 1.90 1.88 1.87 1.86 1.85
.01:
∗lS 1.93 3.82 5.66 7.45 9.21
∗∗lS 1.93 1.93 1.92 1.92 1.91
NOTE.–The ascertainment probability is assumed to be p 
..05
Table 2
Sibling Recurrence-Risk Ratios under the Single-Ascertainment
Scheme
p AND RECURRENCE RISK
VALUE FOR SIBSHIP SIZE OF
2 3 4 5 6
.30:
∗lS 1.54 2.31 2.73 2.97 3.11
∗∗lS 1.54 1.47 1.42 1.37 1.33
.20:
∗lS 1.67 2.71 3.40 3.86 4.18
∗∗lS 1.67 1.61 1.56 1.51 1.47
.10:
∗lS 1.82 3.25 4.39 5.31 6.06
∗∗lS 1.82 1.78 1.75 1.71 1.68
.05:
∗lS 1.90 3.59 5.09 6.42 7.62
∗∗lS 1.90 1.88 1.86 1.84 1.82
.03:
∗lS 1.94 3.75 5.42 6.99 8.44
∗∗lS 1.94 1.93 1.91 1.90 1.89
.01:
∗lS 1.98 3.91 5.80 7.63 9.43
∗∗lS 1.98 1.98 1.97 1.97 1.96
more prominent as the disease frequency (p) decreases.
The magnitude of the inflation can be quite large, es-
pecially for , when sibship size is moderate and p is∗lS
small.
Table 2 lists and under the single-ascertainment∗ ∗∗l lS S
scheme, and the inflation is more prominent. The results
are similar to those of the multiple-ascertainment scheme
with . It is interesting to note that, even forp  .05
, the inflation can be substantial.k  2
Table 3 shows the effect of ascertainment bias and/or
overreporting. Compared with , is very sensitive∗∗ ∗l lS S
to overreporting bias, and the effect of overreporting
can be quite dramatic, especially for smaller p. For ex-
ample, for a false-positive rate of only 5%, increased∗lS
by fivefold for a sibship size of 2. Interestingly, is not∗∗lS
very sensitive to overreporting. In fact, its value de-
creases slightly if there is overreporting.
Discussion
It should be pointed out that there is nothing wrong
in the definition of the sibling recurrence-risk ratio. In
fact, it is a splendid idea—a significant deviation from
unity can be “plausibly interpreted as indicating that the
trait in question has some hereditary background” (Pen-
rose 1953, p. 257), especially in the absence of evidence
that there is an environmental factor. It also has the
appeal of both quantifying the genetic effect without
knowing exactly the mode of inheritance and having the
apparent capability to discriminate between different ge-
netic models if certain assumptions are satisfied (Risch
1990a); and it appears to be measurable, if done with
care. The flip side is that it can easily be misused, as has
been shown above, and is quite sensitive to ascertain-
ment bias and/or overreporting.
Accurate measurement of the sibling recurrence-risk
ratio, a trivially easy task in experimental species, can
be difficult for human geneticists, since random sampling
can be either too expensive or impractical, and since
people do have biases in recalling the events that have
happened in their lives. Althoughwork on ascertainment
bias in human genetics has a long history (for an ex-
cellent review of this subject, see Ewens 1991), dating
from Galton (1904), Weinberg (1912), and Fisher
(1934), we still find genetic epidemiological reports be-
ing published in which the problem is altogether ignored.
This is unfortunate, since the usefulness of many statis-
tical methods for mapping—especially for exclusion
mapping—hinges tightly on an accurate estimation of
the measure.
In this paper, I have considered a fictitious disease that
has neither a genetic component nor an environmental
component. In fact, the manifestation of the disease is
entirely stochastic: the results are similar to those pro-
duced by the tossing of a biased coin. Obviously, such
a disease, if one exists, would be very rare.Most diseases,
especially the chronic ones, have known or suspected
risk factors of environmental origin. If this is the case,
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Table 3
Effect of Ascertainment Bias and/or Overreporting, on Sibling
Recurrence-Risk Ratio, under the Single-Ascertainment Scheme
p AND RECURRENCE RISK
VALUE FOR SIBSHIP SIZE OF
2 3 4 5 6
.30:
∗lS 1.67 2.45 2.84 3.05 3.17
∗∗lS 1.54 1.47 1.41 1.36 1.31
.20:
∗lS 1.94 3.05 3.72 4.15 4.42
∗∗lS 1.67 1.60 1.54 1.49 1.44
.10:
∗lS 2.53 4.33 5.64 6.62 7.35
∗∗lS 1.82 1.76 1.71 1.67 1.63
.05:
∗lS 3.55 6.37 8.63 10.45 11.95
∗∗lS 1.90 1.86 1.82 1.79 1.75
.03:
∗lS 4.85 8.87 12.22 15.04 17.43
∗∗lS 1.94 1.91 1.87 1.84 1.81
.01:
∗lS 11.23 20.95 29.41 36.80 43.29
∗∗lS 1.98 1.95 1.92 1.90 1.87
NOTE.—The false-positive error is assumed to be .a  .05
then and would be measurably higher, as can be∗ ∗∗l lS S
seen from the following numerical example.
Suppose that the population consists only of two-sib-
ling nuclear families. Suppose also that andp  .001
that the frequency of exposure to a risk factor, with a
relative risk of 2, is .35. Suppose further that the familial
correlation in risk exposure is .75 and that the proba-
bilities for ascertaining the families— ,{X  0,X  0}1 2
, , and{X  0,X  1} {X  1,X  0} {X  1,X 1 2 1 2 1 2
—are .125, .125, .25, and .50, respectively. Then,1}
and , when there is no overreport-∗ ∗∗l  4.26 l  2.18S S
ing, and and , when the rate of∗ ∗∗l  97.12 l  3.99S S
overreporting is 5%, both of which are substantially
greater than the 1.09 reported by Khoury et al. (1988,
fig. 2 A, p. 680). Thus, for a disease with known or yet
to be identified risk factor(s) of environmental origin,
the effect of ascertainment bias and/or overreporting
would be more dramatic.
This paper has considered only one or two ascertain-
ment schemes. There are, of course, many other plausible
schemes. Once the scheme is known, adjustment should
be easy to make. In reality, however, the exact ascer-
tainment scheme may not even be clear or known to the
investigator. For example, in a prostate cancer study,
26,781 men age x45 years initially were selected from
an electoral list and were sent a written invitation to
participate in the study. Of this group, only 27.2% in-
dicated their willingness to participate (Narod et al.
1995). It is difficult to determine exactly what motivated
these men to participate; it is even more difficult to de-
termine exactly what motivated others not to do so, in
order to devise an adjustment for ascertainment bias.
Recall bias in epidemiological studies is common
(Raphael 1987; Floderus et al. 1990). Overreporting in
genetic epidemiological studies also is quite common
(Enterline and Capt 1959; Hastrup et al. 1985; Herr-
mann 1985; Hunt et al. 1986; Kee et al. 1993). One
well-documented example of such overreporting or re-
call bias is a case-control study of rheumatoid arthritis,
in which affected individuals are more likely than their
unaffected siblings to report that one or both of their
parents also are affected (Schull and Cobb 1969). In
another epidemiological study, the false-positive ratewas
reported to be 11% (Whittemore et al. 1995). In general,
the overreporting rate varies with many factors, such as
the perceived severity of the disease of interest and the
definition of the disease (J. T. Bensen, A. D. Liese, J. T.
Rushing, M. Province, A. R. Folsom, and D. Arnett,
personal communication).
Although this article has focused only on the sibling
recurrence-risk ratio, the results can be generalized to
the recurrence-risk ratio for other relative pairs. As is
true for the difference in sibship size, different individ-
uals may have different numbers of aunts, uncles, and
offspring.
It should be noted that some genetic epidemiological
studies, such as those conducted by Bailey and Benishay
(1993) and Pillard and Weinrich (1986), do not specif-
ically use the sibling recurrence-risk ratio to measure
familial aggregation. However, because the sampling is
always prone to both ascertainment bias (especially for
traits that carry a social stigma) and overreporting, the
potential for misinterpretation of data always exists.
The correct way to estimate lS is, of course, to try to
correct for ascertainment bias and/or overreporting er-
ror. This may not be an easy task. What one could do
is to avoid the use of definitions (2) or (3), by specifying
a priori which sib will be taken to be sib2. For example,
one can specify, in advance, that either the immediately
older sibling is to be ascertained or, if the latter is not
available, the immediately younger sibling.
It is somewhat surprising that the ascertainment bias,
coupled with overreporting, can substantially inflate the
sibling recurrence-risk ratio. This result demonstrates
that, just like segregation analysis, the estimation of the
ratio is not immune to ascertainment bias. It further
underscores the difficulty in establishing compelling ev-
idence that the disease or disorder has a genetic com-
ponent. In an era when gene mapping relies increasingly
on brute-force procedures such as genomewide scanning
(whether in an association study or not), this should
cause sobering alarm, since what have been hunted
might well be phantom genes.
This also raises the question of the extent to which
we should trust the estimates of recurrence-risk ratios
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reported in some genetic epidemiological studies of com-
plex diseases, studies that apparently have not made any
attempt to correct for ascertainment bias and/or over-
reporting. Perhaps extreme caution is needed when, on
the basis of these estimates, one either performs exclu-
sion mapping or discriminates between different genetic
models. It is perhaps timely to heed the advice given by
the late R. A. Fisher in his well-known paper on ascer-
tainment bias, published 65 years ago: “It is a statistical
commonplace that the interpretation of a body of data
requires a knowledge of how it was obtained” (Fisher
1934, p. 13).
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